MIM
SMTI icon

MetLife Investment Management’s Sanara MedTech SMTI Stock Holding History

MetLife Investment Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,656
Closed -$82K – 2920
2025
Q1 		$82K Buy
+2,656
New +$90.2K ﹤0.01% 2604
2024
Q2 		– Sell
-2,147
Closed -$79.4K – 2918
2024
Q1 		$79.4K Hold
2,147
– – ﹤0.01% 2632
2023
Q4 		$88.2K Hold
2,147
– – ﹤0.01% 2656
2023
Q3 		$66.8K Hold
2,147
– – ﹤0.01% 2781
2023
Q2 		$86.1K Buy
+2,147
New +$87.8K ﹤0.01% 2765

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MetLife Investment Management's SMTI Position: Q2 2025 in Review

MetLife Investment Management sold out of Sanara MedTech (SMTI) in Q2 2025, closing a stake of 2,656 shares — an estimated $82K sold.

MetLife Investment Management first reported a position in SMTI in Q2 2023 and held it in 5 quarters. The position peaked at $88.2K in Q4 2023. 52 funds tracked by Wall St. Rank hold SMTI as of Q2 2025.

  • MetLife Investment Management reported no remaining Sanara MedTech position as of Q2 2025 after selling out during the quarter.
  • MetLife Investment Management sold 2,656 Sanara MedTech shares in Q2 2025, an estimated $82K.
  • MetLife Investment Management first reported a position in Sanara MedTech in Q2 2023 and held it in 5 quarters.
  • MetLife Investment Management's Sanara MedTech position peaked at $88.2K in Q4 2023.
  • 52 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2025.

Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.